Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Summary

Multiple myeloma is a disease of B-lymphocytes producing malignant plasma cells. Malignant plasma cells induce osteolytic lesions, which is characteristic for progression of multiple myeloma. It is the aim of this study to investigate whether zoledronic acid has an influence on the progression of multiple myeloma.

Timeline

Start

2000-08

Primary completion

2008-11

Completion

2008-11

Outcome

Outcome not reported

Stopped (Enrollment): “Recruitment in study could not be reached after 8 yrs of recruiting”

Drugs

Indications